SCOPUS 정보 검색 플랫폼

Volumn 75, Issue SUPPL. 1, 2002, Pages

Overview of luteinizing hormone-releasing hormone agonists in early breast cancer - Benefits of reversible ovarian ablation

(1) Jonat, Walter a

a UNIVERSITY OF KIEL (Germany)

Author keywords

'Zoladex'; Goserelin; Luteinizing hormone releasing hormone; Ovarian ablation; Premenopausal

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; GONADORELIN AGONIST; GOSERELIN; METHOTREXATE; TAMOXIFEN;

ALOPECIA; AMENORRHEA; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; EARLY CANCER; HORMONE SENSITIVITY; HOT FLUSH; HUMAN; INFECTION; INTERMETHOD COMPARISON; LONG TERM CARE; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT PLANNING; VOMITING;

EID: 0036776509 PISSN: 01676806 EISSN: None Source Type: Journal
DOI: 10.1023/a:1020309715942 Document Type: Review

Times cited : (12)

References (16)

1
- 50549123220
- On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases
- (1896) Lancet , vol.2 , pp. 104-107
- Beatson, G.T.¹

2
- 0029806829
- Ovarian ablation in early breast cancer: Overview of the randomized trials
- (1996) Lancet , vol.348 , pp. 1189-1196

3
- 0034724908
- Factors associated with early menopause
- (2000) Maturitas , vol.35 , pp. 3-9
- Harlow, B.L.¹ Signorello, L.B.²

4
- 0024797913
- Pharmacology of the luteinising hormone-releasing hormone (LHRH) analogue, Zoladex
- (1989) Horm Res , vol.32 , Issue.SUPPL. 1 , pp. 86-92
- Furr, B.J.¹

5
- 0033985638
- Prognostic effect of amenorrhea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients
- (2000) Eur J Cancer , vol.36 , pp. 43-48
- Poikonen, P.¹ Saarto, T.² Elomaa, I.³ Joensuu, H.⁴ Blomqvist, C.⁵

6
- 0030902633
- Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: Prognostic role and clinical implications
- (1997) Breast Cancer Res Treat , vol.43 , pp. 183-190
- Del Mastro, L.¹ Venturini, M.² Sertoli, M.R.³ Rosso, R.⁴

7
- 0032736260
- The risk of premature menopause induced by chemotherapy for early breast cancer
- (1999) J Womens Health Gend Based Med , vol.8 , pp. 949-954
- Lower, E.E.¹ Blau, R.² Gazder, P.³ Tummala, R.⁴

8
- 0003208197
- Zoladex™ versus CMF adjuvant therapy in pre/perimenopausal breast cancer: Tolerability and amenorrhea comparisons
- abstract 333
- (2000) Proc ASCO , vol.19
- Jonat, W.¹

9
- 0003071559
- Zoladex™ (goserelin) versus CMF as adjuvant therapy in pre/perimenopausal, node-positive, early breast cancer: Preliminary efficacy results from the ZEBRA study
- abstract P53
- (2001) Breast , vol.10 , Issue.SUPPL. 1
- Kaufmann, M.¹

10
- 0005381822
- Early benefits in Quality of Life (QoL) observed in Zoladex®-treated versus CMF-treated pre/perimenopausal patients with node-positive early breast cancer
- San Francisco, CA, USA, May 12-15, abstract 138
- (2001) ASCO 2001
- De Haes, H.¹ Olschewski, M.² Schumacher, M.³ Kaufmann, M.⁴ Jonat, W.⁵

11
- 0005374107
- Assessment of bone mineral density in pre/perimenopausal women treated with 'Zoladex' versus CMF adjuvant therapy for node-positive, early breast cancer: Results from the ZEBRA study
- St Gallen, Switzerland, February 21-24
- (2001) 7th International Conference on Adjuvant Therapy of Primary Breast Cancer
- Fogelman, I.¹

12
- 0001838971
- Complete endocrine blockade with tamoxifen and goserelin is superior to CMF in the adjuvant treatment of premenopausal, lymph node-positive and negative patients with hormone-responsive breast cancer
- abstract S26
- (2001) Breast , vol.10 , Issue.SUPPL. 1
- Jakesz, R.¹ Hausmaninger, H.² Samonigg, H.³ Kubista, E.⁴ Gnant, M.⁵ Menzel, C.⁶ Bauernhofer, T.⁷ Seifert, M.⁸ Haider, K.⁹ Steger, G.¹⁰ Mlinerltsch, B.¹¹ Stelndorfer, P.¹² Kwasny, W.¹³ Fridrlk, M.¹⁴ Wette, V.¹⁵

13
- 0002246459
- Adjuvant Zoladex in premenopausal patients with early breast cancer: Results from the ZIPP trial
- Abstract presented at the 7th International Conference on Adjuvant Therapy of Primary Breast Cancer, St Gallen, Switzerland, February 21-24, 2001 (abstract P64)
- (2001) Breast , vol.10 , Issue.SUPPL. 1
- Baum, M.¹ Houghton, J.² Odling-Smee, W.³ Rutqvist, L.E.⁴ Fornander, T.⁵ Nordenskjold, B.⁶ Nicolucci, A.⁷ Mari, E.⁸

14
- 0000911825
- Effect of chemohormonal therapy in premenopausal, node-positive, receptor-positive breast cancer: An Eastern Cooperative Oncology Group Phase III Intergroup Trial (E5188, INT-0101)
- abstract 249
- (1999) Breast , vol.8 , pp. 232-233
- Davidson, N.¹ O'Neill, A.² Vukov, A.³

15
- 0035806484
- National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000
- (2001) J Natl Cancer Inst , vol.4-9 , pp. 979-989
- Eifel, P.¹ Axelson, J.A.² Costa, I.³ Crowley, J.⁴ Curran W.J., Jr.⁵ Deshler, A.⁶ Fulton, S.⁷ Hendricks, C.B.⁸ Kemeny, M.⁹ Kornblith, A.B.¹⁰ Louis, T.A.¹¹ Markman, M.¹² Mayer, R.¹³ Roter, D.¹⁴

16
- 0035884636
- Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
- 7th International Conference on Adjuvant Therapy of Primary Breast Cancer
- (2001) J Clin Oncol , vol.19 , pp. 3817-3827
- Goldhirsch, A.¹ Glick, J.H.² Gelber, R.D.³ Coates, A.S.⁴ Senn, H.J.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.